Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

10.46 +1.17 (+12.59%)
Delayed Quote Updated: 12:10 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Churchill Capital Corp XI - Class A Ordinary Shares

< Previous 1 2 3 4 Next >
News headline image
Agility Robotics and Churchill Capital Corp XI Announce Expected Gross Capital Raise of Approximately $465 Million and Anticipated Closing of Business Combination
From Agility Robotics, Inc
Via GlobeNewswire
News headline image
Agility Robotics Highlights Commercial Momentum and Growing Enterprise Demand for Digit Humanoid Robot
From Agility Robotics, Inc
Via GlobeNewswire
News headline image
Agility Robotics Expands NVIDIA Collaboration as It Prepares Digit 5 for Commercial Scale
Digit 5 Will Consolidate Onboard Compute to NVIDIA IGX Thor Modules, Building on Companies’ Humanoid Safety Collaboration 
From Agility Robotics, Inc
Via GlobeNewswire
News headline image
Agility Robotics Expands Pittsburgh Presence to Support Growing Customer Deployments
From Agility Robotics, Inc
Via GlobeNewswire
News headline image
AGCO and Agility Robotics Advance Smart Manufacturing with Humanoid Robot Pilot in Hesston, Kansas, Facility
AGCO to Explore Digit Robot Use in Manufacturing Operation for Repetitive, Hazardous Tasks 
From Agility Robotics, Inc
Via GlobeNewswire
News headline image
Agility Robotics Announces Audit Committee Chair for Planned Public-Company Board
Global Logistics, Finance and Investment Leader to Support Agility’s Commercial Expansion and Public-Company Governance 
From Agility Robotics, Inc
Via GlobeNewswire
News headline image
Agility Robotics and Churchill Capital Corp XI S-4 Registration Statement Declared Effective by SEC in Connection with Proposed Business Combination
From Agility Robotics, Inc.
Via Business Wire
News headline image
Agility Robotics to Livestream Analyst & Investor Day Today
From Agility Robotics
Via Business Wire
News headline image
Agility Robotics Announces New Directors for Planned Public-Company Board
From Agility Robotics
Via Business Wire
News headline image
Agility to Host Analyst & Investor Day on October 6, 2026
From Agility Robotics
Via Business Wire
News headline image
Agility Robotics to Attend Upcoming Investor Conferences
From Agility Robotics
Via Business Wire
News headline image
Agility Robotics and Churchill Capital Corp XI Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
From Agility Robotics, Inc.
Via Business Wire
News headline image
Agility Robotics to Go Public Through $2.5 Billion Merger with Churchill Capital Corp XI
From Agility Robotics, Inc.
Via Business Wire
News headline image
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
From ChemoCentryx, Inc.
Via GlobeNewswire
News headline image
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From ChemoCentryx, Inc.
Via GlobeNewswire
News headline image
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
ChemoCentryx (NASDAQ: CCXI) to be Acquired by Amgen (NASDAQ: AMGN) for $3.7 Billion in Cash
ChemoCentryx, Inc. (NASDAQ: CCXI) is engaged as a biopharmaceutical company that is focused on the research, development and commercialization of 
Via Spotlight Growth
News headline image
CCXI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of ChemoCentryx, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
News headline image
NASDAQ: CCXI Investor Notice: Update in Lawsuit Against ChemoCentryx, Inc. Announced ↗
San Diego, CA -- (SBWIRE) -- 04/26/2022 -- An update was announced in the lawsuit that is pending for certain investors in in shares of ChemoCentryx, Inc. (NASDAQ: CCXI) against ChemoCentryx, Inc.over... 
Via SBWire
News headline image
CHEMOCENTRYX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ChemoCentryx, Inc. - CCXI
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
NASDAQ:CCXI Long Term Investor Alert: Investigation of Potential Wrongdoing at ChemoCentryx, Inc. ↗
San Diego, CA -- (SBWIRE) -- 02/24/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of ChemoCentryx, Inc. 
Via SBWire
News headline image
NASDAQ:CCXI Investor Notice: Investigation over Possible Securities Laws Violations by ChemoCentryx, Inc. ↗
San Diego, CA -- (SBWIRE) -- 02/22/2022 -- ChemoCentryx, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
SHAREHOLDER ALERT: Robbins LLP Investigates ChemoCentryx, Inc. (CCXI) on Behalf of Shareholders
From Robbins LLP
Via Business Wire
News headline image
NASDAQ:CCXI Long Term Shareholder Notice: Investigation over Potential Wrongdoing at ChemoCentryx, Inc. ↗
San Diego, CA -- (SBWIRE) -- 09/15/2021 -- Certain directors of ChemoCentryx, Inc. are under investigation concerning potential breaches of fiduciary duties. 
Via SBWire
Topics Lawsuit
News headline image
CCXI DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of ChemoCentryx, Inc. of Deadline in Securities Fraud Class Action Lawsuit
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
CHEMOCENTRYX 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against ChemoCentryx, Inc. - CCXI
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
CCXI CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ChemoCentryx, Inc.
NEW YORK, NY / ACCESSWIRE / June 30, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class... 
From Bernstein Liebhard LLP
Via AccessWire
Topics Lawsuit
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
From The Law Offices of Frank R. Cruz
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.